National Institutes Of Health

President Joe Biden plans to nominate NCI Director Monica M. Bertagnolli, MD, FACS, FASCO, to serve as director of the NIH, according to published reports.

Data from four large studies with ancestry data show there are “clear differences” in associations between triglyceride levels with known cardiometabolic risk factors for people from West African, East African and European backgrounds.

The NIH announced a trial it is funding has been stopped early because an interim analysis found daily statin use greatly prevented major adverse CV events in people living with HIV.

A team of three Ohio research companies has won a seat on an 8-year, $149 million indefinite delivery, indefinite quantity contract vehicle for the National Institute of Neurological Disorders and Stroke.

Chimeric antigen receptor T-cell therapy targeting CD19 is highly effective for inducing remission among patients with relapsed or refractory B-cell acute lymphoblastic leukemia.

Individualized care and patient satisfaction are among the areas of emphasis in a new consensus statement on management of thyroid eye disease.

The NIH announced it has established a research network that aims to test harm reduction strategies in different community settings affected by opioid use to inform efforts to help save lives.

At the end of this month, Anthony S. Fauci, MD, will officially step down as director of the National Institute of Allergy and Infectious Diseases, which he has led for nearly 4 decades.

Monica M. Bertagnolli, MD, FACS, FASCO, director of the NCI, announced today that she has been diagnosed with early-stage hormone receptor-positive, HER2-negative breast cancer.

COVID-19 was in so many ways an inflection point for nearly all aspects of health care, with one of the most conspicuous, continuing examples of “pre-2020” differing from “post-2020” being the way people consume data from meetings.